谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Neoadjuvant SHR-1701 with or Without Chemotherapy in Unresectable Stage III NSCLC (TRAILBLAZER): Efficacy, Safety and Feasibility of Surgical Conversion Outcomes from a Proof-of-concept, Phase 2 Trial.

Yi-Long Wu,Qing Zhou,Yi Pan,Xue-Ning Yang,Yanqiu Zhao,Guang Han,Qingsong Pang,Zhenfa Zhang,Qifeng Wang,Jun Yao, Hui Wang,Weihua Yang,Baogang Liu,Qixun Chen,Xianghui Du,Kaican Cai,Baosheng Li, Xiao Li, Li Song, Wei Shi

Journal of Clinical Oncology（2024）

引用 0|浏览9
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要